Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy.
Fondazione Salesi, Ospedale G. Salesi, 60100 Ancona, Italy.
Cells. 2024 Sep 1;13(17):1469. doi: 10.3390/cells13171469.
NAD-dependent deacetylase sirtuin-1 (Sirt1) belongs to the sirtuins family, known to be longevity regulators, and exerts a key role in the prevention of vascular aging. By aging, the expression levels of Sirt1 decline with a severe impact on vascular function, such as the rise of endothelial dysfunction, which in turn promotes the development of cardiovascular diseases. In this context, the impact of Sirt1 activity in preventing endothelial senescence is particularly important. Given the key role of Sirt1 in counteracting endothelial senescence, great efforts have been made to deepen the knowledge about the intricate cross-talks and interactions of Sirt1 with other molecules, in order to set up possible strategies to boost Sirt1 activity to prevent or treat vascular aging. The aim of this review is to provide a proper background on the regulation and function of Sirt1 in the vascular endothelium and to discuss the recent advances regarding the therapeutic strategies of targeting Sirt1 to counteract vascular aging.
NAD 依赖的去乙酰化酶 Sirtuin-1(Sirt1)属于 Sirtuins 家族,已知是长寿调节剂,并在预防血管老化方面发挥关键作用。随着年龄的增长,Sirt1 的表达水平下降,严重影响血管功能,如内皮功能障碍的增加,进而促进心血管疾病的发展。在这种情况下,Sirt1 活性在预防内皮衰老中的作用尤为重要。鉴于 Sirt1 在对抗内皮衰老中的关键作用,人们已经做出了巨大的努力来加深对 Sirt1 与其他分子之间复杂的串扰和相互作用的了解,以便制定可能的策略来提高 Sirt1 的活性,以预防或治疗血管衰老。本综述的目的是提供 Sirt1 在血管内皮中的调节和功能的适当背景,并讨论靶向 Sirt1 以对抗血管衰老的治疗策略的最新进展。